Search Results: immunotherapy

• Health & Medicine

Coronavirus and cancer – latest updates

We're pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer. We're pulling together the latest government and NHS health updates concerning coronavirus (COVID-19) and cancer.

19 March 2020

• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Science & Technology
• Health & Medicine

News digest – robot surgery, cancer information, drug decisions and prebiotics

In the news this week: A survey has revealed a third of cancer patients fail to receive vital information and robots are used in breast cancer surgery. In the news this week: A survey has revealed a third of cancer patients fail to receive vital information and robots are used in breast cancer surgery.

15 February 2020

• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• Science & Technology
• Health & Medicine

News digest – cataloguing cancer genomes, gene-edited immune cells and NHS finances

In the news this week: scientists have completed the most comprehensive study of cancer genetics to date. In the news this week: scientists have completed the most comprehensive study of cancer genetics to date.

8 February 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Science & Technology
• Health & Medicine

News digest – transforming clinical trials, AI and brain surgery, vaping and breast cancer genetics

In the news this week: our scientists want to transform the way clinical trials are run and 191 genes are linked to breast cancer development in new research. In the news this week: our scientists want to transform the way clinical trials are run and 191 genes are linked to breast cancer development in new research.

11 January 2020

• For Supporters

Introducing Trailblazers – our new philanthropic initiative to back research’s rising stars

We investigate how a new philanthropic programme is offering a flying start to early-career scientists We investigate how a new philanthropic programme is offering a flying start to early-career scientists

10 January 2020

• For Supporters

In conversation with our Chair, Sir Borys - Finding answers to the whys

In the first of a two-part interview, we chart the remarkable journey to knighthood of Chair of Cancer Research UK, Professor Sir Leszek Borysiewicz. In the first of a two-part interview, we chart the remarkable journey to knighthood of Chair of Cancer Research UK, Professor Sir Leszek Borysiewicz.

13 December 2019

• Health & Medicine

Bladder cancer treatment rejected for routine use on NHS in England


A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England. 
A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England.

26 November 2019

• For Supporters

‘5 in 5’ with Alison Howe

We take five with Alison Howe, who shares her journey from lab researcher to cancer survivor, Cancer Research UK board member and legacy pledger. We take five with Alison Howe, who shares her journey from lab researcher to cancer survivor, Cancer Research UK board member and legacy pledger.

22 November 2019